In March 2022, Carey-Ann joined Pattern as Chief Clinical Officer and in December of 2024 she was named Chief Executive Officer. Carey-Ann has nearly 20 years of experience as a clinical microbiologist and leader; prior to joining Pattern, she served as a professor of pathology and immunology, molecular microbiology, pediatrics, and medicine at Washington University School of Medicine in St. Louis, and the medical director of clinical microbiology at Barnes-Jewish Hospital. Carey-Ann is passionate about innovation in diagnostics and the thoughtful use of technology to improve human health, and is a respected leader and investigator in the clinical microbiology and infectious disease space.

Carey-Ann has been recognized with industry awards including the American Society for Microbiology Award for Research and Leadership in Clinical Microbiology, the Academy of Clinical Laboratory Physicians and Scientists Ellis S. Benson Award, and recognition as a “40 Under 40” honoree by the American Society for Clinical Pathology. Carey-Ann has more than 300 peer-reviewed publications and has held several leadership roles in clinical microbiology, including serving as an editor for the Journal of Clinical Microbiology, co-editor in chief for Clinical Microbiology Procedures Handbook, 5th ed., and serving as the founding editor-in-chief for ASM Case Reports, a new journal from the American Society for Microbiology.

Nick founded Pattern in 2016 when, after a decade in diagnostics, he asked himself: “why does it still take almost a week to diagnose something as common and fast-moving as a life-threatening bacterial infection?” The answer, he realized, resided in the surprising complexity of bacterial resistance and that bacterial infections, like cancer, required targeted treatment of a few “bad cells” living in a sea of “good cells”.  An electrical engineer by training, Nick suspected that single-cell isolation using a type of biochemical “digitization” could quickly and accurately reveal the key resistance and population characteristics of an infection.  He founded Pattern with the goal of drastically improving antibiotic treatment decisions. Before Pattern, Nick held various leadership positions at Luminex, most recently serving as Sr. Director of the Advanced Technology Group. He is the primary inventor on over ten patents, twice winning Luminex’s “Top Inventor” award. Nick obtained his B.S. in Electrical Engineering at UT Austin.

Kelly is the Senior Director of Program Management and Quality at Pattern, where she leads program planning and tracking for the development, validation, and FDA clearance of Pattern’s Single-Cell Microbiology system and test panels. She also manages the Quality team, overseeing the implementation and maintenance of compliance and execution in the quality system. Before stepping into this role, she led consumable manufacturing at Pattern, scaling production processes, building out a cleanroom, and establishing a supply chain foundation to support pre-clinical studies.

With more than 15 years of experience in medical device manufacturing, Kelly has a proven track record in leading cross-functional teams for new product development, design transfer, and continuous improvement. Her expertise spans negative pressure wound therapy systems, ENT dissolvable dressings, and cryopreservation CAR-T therapy accessories. Kelly is passionate about teamwork and the philosophy that a rising tide lifts all boats.

Jacob joined Pattern as a Machine Learning Engineer in August 2019. He brings expertise in data science and computational modeling which he has applied to problems in materials science, nanotechnology, and healthcare. Jacob obtained a PhD from the University of Illinois at Urbana-Champaign where he was supported by the prestigious National Science Foundation Graduate Research Fellowship. His work included the development of a novel method for the calculation of vibrational properties of molecules which was recognized by the American Chemical Society with the Chemical Computing Group Excellence Award for Graduate Students. Jacob obtained a B.S in Chemistry with highest honors from Louisiana Tech University.

Eric serves as Director of Product Marketing at Pattern, where he leads go-to-market strategy and commercial readiness for Pattern’s Single-Cell Microbiology system and its rapid identification and antimicrobial susceptibility testing (ID/AST) panels. He focuses on translating the platform into clear clinical value for the laboratories Pattern serves as the company moves toward commercialization.

Eric brings more than 15 years of experience in clinical microbiology and diagnostics. Most recently at bioMérieux, he led U.S. commercialization for VITEK® REVEAL™, a novel rapid AST platform, and drove product marketing across the $100M+ VITEK® 2 ID/AST portfolio. Earlier at bioMérieux, he guided customers through implementation and training across ID/AST and blood culture platforms as a Senior Customer Learning and Development Specialist, building on years at the bench as a senior medical technologist. He holds a STEM MBA from North Carolina State University.

Natalie is excited to be part of the interdisciplinary, imaginative, and dedicated team at Pattern, where she serves as the Director of Assay Development. She is driven by solving problems that are simultaneously difficult and impactful. She has a Ph.D. in physical chemistry from the University of Colorado at Boulder and a B.A. from Grinnell College in chemistry. After completing her Ph.D. work on singlet and triplet exciton dissociation in organic photovoltaics, she became inspired by technologies emerging at the intersection between photophysics and biology. She was awarded a Director’s Postdoctoral Fellowship by Los Alamos National Laboratory, where she developed novel methods to detect interactions between DNA, RNA, and proteins in complex cellular environments.

Kyle joined Pattern in April 2018, bringing a dynamic blend of clinical diagnostics expertise and strategic growth acumen to the team. His tenure in health technology spans more than 20 years and includes impactful leadership roles at Luminex Corporation in Global Strategic Marketing and Corporate Development. At Luminex, Kyle was pivotal in nurturing key partnerships and steering strategic investments to drive growth in the company’s molecular diagnostics franchise. His earlier career encompasses diverse roles in marketing, sales, and consulting at Abbott Laboratories and Cerner Corporation.

Kyle holds an MBA from Kellogg School of Management, Northwestern University, with a focus on health industry management, and dual degrees in Finance and Music from Truman State University.

David joined Pattern as VP of Research & Development in June of 2017. He brings over 15 years’ of research and development experience. He is currently responsible for taking products through clearance with oversight of Product Development, Clinical Affairs, and Regulatory Affairs. Prior to joining Pattern, David held leadership roles of increasing responsibility at Luminex. While at Luminex, he led teams responsible for product development across the maturity continuum from early technology assessment to commercialization. This included the launch of multiple regulated products (CE-IVD, IVD) in the US and abroad. David has also contributed to the development of advanced DNA sequencing technologies at Life Technologies and held a Distinguished Post-Doctoral Fellowship in the Center of Integrated Nanotechnologies at Los Alamos National Laboratory.

David holds a B.S. in Chemistry from the University of Nebraska with High Honors and a Ph.D. from the University of California at Santa Barbara.

Ross is a leader in Pattern’s long-term technical vision and provides strategic oversight of key aspects of Pattern’s diagnostic platform. Over the past decade, he has seven issued patents and four patents pending. He is an expert in droplet microfluidics with eleven years’ experience developing FDA-cleared products and technologies. Prior to co-founding Pattern, Ross served as a senior mechanical engineer at Luminex Corporation where he won the company’s “Top Inventor” award in 2010 and again in 2014 (as co-inventor with Nick). Ross has an M.S. in Mechanical Engineering from the University of Texas at Austin and a B.S. in Mechanical Engineering with Honors from the University of New Mexico.

Cindy joined Pattern as Director of People & Culture in October 2019 to champion a collaborative and engaging culture and workplace. Prior to joining Pattern, Cindy built the people systems and initiatives at Wheelhouse DMG in Seattle, focused on cultivating joy in best place to work environments. In any workplace, her goal is to be an advocate and partner to all team members. Cindy received her B.B.A in Economics and Accounting from Baylor University and is a Society for Human Resources Management Certified Professional. When she’s not exploring the craft brewery scene in Austin, you might find her walking her dog or volunteering in the city.

Brian joined Pattern to lead instrument development on Pattern’s engineering team in 2021. He brings 9 years of product development leadership experience across multiple industries including renewable energy, industrial equipment, and medical device. He is passionate about making products that bring large social impact and provide lasting value to customers. Brian has obtained 4 patents and has 3 patents pending. He holds bachelor’s degrees in mechanical engineering and Plan II from the University of Texas at Austin and a master’s degree in mechanical engineering from Stanford University.

Jonathan joined Pattern as a Principal Mechanical Engineer in January 2020 with over 20 years of experience in various industries including 5 years in biomedical.  Jonathan has been a lead or senior engineer developing multiple on market systems such as a ruggedized computer for a Dell OEM to a high pressure actuator and swivel at an oilfield technology company.  Within biomedical, Jonathan worked as a Senior Mechanical Engineer at Luminex helping to develop one of their current on market products and updating two of their legacy products.  He has an extensive experience in injection molded design and patents in two different industries.  Jonathan holds a B.S. in Mechanical Engineering from the University of Texas at Austin.

Vanessa is the Quality Manager for Pattern Bioscience and has been a member of the team since June 2023. Vanessa has more than 10 years of quality and engineering experience. Prior to joining Pattern, she worked for a variety of companies in the medical device and pharmaceutical industries, including Smith & Nephew, Integra Life Sciences, ICU Medical, and Pfizer. During her career, Vanessa has supported audits by several agencies, including the FDA. Vanessa is passionate about building quality processes that ensure patient safety and enable compliant operations. She holds a B.S. in Biomedical Engineering from the University of Texas at Austin and an MBA with a focus in healthcare administration from Baylor University.

David serves as Vice President of Sales, bringing over 17 years of commercial diagnostics experience to Pattern Bioscience. His career has been defined by building high-performing sales teams at innovative diagnostic startups — two of which were acquired by global industry leaders. Most recently, David served as VP of Sales at Specific Diagnostics before its acquisition by bioMérieux in 2022, and prior to that he served as Senior Director of Sales at GenMark Diagnostics ahead of its $1.8B acquisition by Roche in 2021.